middle.news
Neuren’s DAYBUE Royalties Hit Record A$65M as 2026 Sales Set to Surge
11:42am on Thursday 26th of February, 2026 AEDT
•
Pharmaceuticals
Read Story
Neuren’s DAYBUE Royalties Hit Record A$65M as 2026 Sales Set to Surge
11:42am on Thursday 26th of February, 2026 AEDT
Key Points
2025 DAYBUE net sales reached US$391 million, up 12% year-on-year
Neuren’s 2025 royalty income rose 15% to A$65 million
Q4 2025 DAYBUE shipments served a record 1,070 patients
2026 sales guidance of US$460–490 million implies royalties of A$70–77 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NEUREN PHARMACEUTICALS (ASX:NEU)
OPEN ARTICLE